BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 15767446)

  • 1. The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus.
    Ida-Hosonuma M; Iwasaki T; Yoshikawa T; Nagata N; Sato Y; Sata T; Yoneyama M; Fujita T; Taya C; Yonekawa H; Koike S
    J Virol; 2005 Apr; 79(7):4460-9. PubMed ID: 15767446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of neuropathogenicity of poliovirus in two transgenic mouse strains expressing human poliovirus receptor with different distribution patterns.
    Ida-Hosonuma M; Iwasaki T; Taya C; Sato Y; Li J; Nagata N; Yonekawa H; Koike S
    J Gen Virol; 2002 May; 83(Pt 5):1095-1105. PubMed ID: 11961264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis.
    Ren RB; Costantini F; Gorgacz EJ; Lee JJ; Racaniello VR
    Cell; 1990 Oct; 63(2):353-62. PubMed ID: 2170026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice.
    Ren R; Racaniello VR
    J Virol; 1992 Jan; 66(1):296-304. PubMed ID: 1370085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Transgenic Mouse Model of Poliomyelitis.
    Koike S; Nagata N
    Methods Mol Biol; 2016; 1387():129-44. PubMed ID: 26983733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of three different transgenic mouse lines that carry human poliovirus receptor gene--influence of the transgene expression on pathogenesis.
    Koike S; Taya C; Aoki J; Matsuda Y; Ise I; Takeda H; Matsuzaki T; Amanuma H; Yonekawa H; Nomoto A
    Arch Virol; 1994; 139(3-4):351-63. PubMed ID: 7832641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poliovirus pathogenesis in a new poliovirus receptor transgenic mouse model: age-dependent paralysis and a mucosal route of infection.
    Crotty S; Hix L; Sigal LJ; Andino R
    J Gen Virol; 2002 Jul; 83(Pt 7):1707-1720. PubMed ID: 12075090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A poliomyelitis model through mucosal infection in transgenic mice bearing human poliovirus receptor, TgPVR21.
    Nagata N; Iwasaki T; Ami Y; Sato Y; Hatano I; Harashima A; Suzaki Y; Yoshii T; Hashikawa T; Sata T; Horiuchi Y; Koike S; Kurata T; Nomoto A
    Virology; 2004 Mar; 321(1):87-100. PubMed ID: 15033568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathogenesis of poliomyelitis: what we don't know.
    Nathanson N
    Adv Virus Res; 2008; 71():1-50. PubMed ID: 18585526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One hundred years of poliovirus pathogenesis.
    Racaniello VR
    Virology; 2006 Jan; 344(1):9-16. PubMed ID: 16364730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poliovirus-sensitive transgenic mice as a new animal model.
    Koike S; Horie H; Sato Y; Ise I; Taya C; Nomura T; Yoshioka I; Yonekawa H; Nomoto A
    Dev Biol Stand; 1993; 78():101-7. PubMed ID: 8388819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular mechanism of tissue-specific infection of poliovirus].
    Koike S
    Uirusu; 2004 Dec; 54(2):205-12. PubMed ID: 15745158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited trafficking of a neurotropic virus through inefficient retrograde axonal transport and the type I interferon response.
    Lancaster KZ; Pfeiffer JK
    PLoS Pathog; 2010 Mar; 6(3):e1000791. PubMed ID: 20221252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple host barriers restrict poliovirus trafficking in mice.
    Kuss SK; Etheredge CA; Pfeiffer JK
    PLoS Pathog; 2008 Jun; 4(6):e1000082. PubMed ID: 18535656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic mice and the pathogenesis of poliomyelitis.
    Racaniello VR; Ren R
    Arch Virol Suppl; 1994; 9():79-86. PubMed ID: 8032284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor.
    Yang WX; Terasaki T; Shiroki K; Ohka S; Aoki J; Tanabe S; Nomura T; Terada E; Sugiyama Y; Nomoto A
    Virology; 1997 Mar; 229(2):421-8. PubMed ID: 9126254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha/beta interferon promotes transcription and inhibits replication of borna disease virus in persistently infected cells.
    Staeheli P; Sentandreu M; Pagenstecher A; Hausmann J
    J Virol; 2001 Sep; 75(17):8216-23. PubMed ID: 11483767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice.
    Abe S; Ota Y; Koike S; Kurata T; Horie H; Nomura T; Hashizume S; Nomoto A
    Virology; 1995 Feb; 206(2):1075-83. PubMed ID: 7856082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular basis of poliovirus neurovirulence.
    Ohka S; Nomoto A
    Dev Biol (Basel); 2001; 105():51-8. PubMed ID: 11763337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poliovirus attenuation and pathogenesis in a transgenic mouse model for poliomyelitis.
    Racaniello VR; Ren R; Bouchard M
    Dev Biol Stand; 1993; 78():109-16. PubMed ID: 8388820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.